Figure legends
Figure 1: The flow chart of literature retrieval of this meta-analysis
Figure 2. A summary graph of pooled results for associations between
polypharmacy and outcomes in AF patients.
AF=atrial fibrillation; SSE=stroke or systemic embolism; CI=confidence
interval; IV=inverse of the variance; SE=standard error.
Figure 3. Forest plot for comparing the SSE of NOACs with VAKs in AF
patients with polypharmacy.
SSE=stroke or systemic embolism;
NOACs=non–vitamin K antagonist oral anticoagulants; VKAs=vitamin K
antagonists; AF=atrial fibrillation; CI=confidence interval; IV=inverse
of the variance; SE=standard error.
Figure 4. Forest plot for comparing the major bleeding of NOACs with
VAKs in AF patients with polypharmacy.
NOACs=non–vitamin K antagonist oral anticoagulants; VKAs=vitamin K
antagonists; AF=atrial fibrillation; CI=confidence interval; IV=inverse
of the variance; SE=standard error.